Field Medical Director: Cutaneous Oncology & KOL Strategy

Regeneron Pharmaceuticals, Inc.; United States; Hybrid; USD 176,000 - 287,000; Full time

Job summary

Regeneron Pharmaceuticals is seeking an Associate Director, Field Medical Affairs to build and maintain crucial KOL relationships across solid tumors and related oncology areas. You will serve as a primary clinical/scientific resource for HCPs and researchers, guiding evidence generation and educational initiatives.

Approximately 50% travel, territory ownership, and strong compliance with FDA/pharma regulations are expected as you contribute to strategic medical plans and interact with

Qualifications

• Terminal scientific degree required.
• 8+ years of experience with a minimum of 4 years experience in Oncology Medical Science Liaison function.
• Knowledge of oncology guidelines, clinical research processes, and pharma regulations.
• Willingness to travel approximately 50% with territory residency and valid drivers license.

Responsibilities

• Establish and maintain peer relationships with KOLs.
• Act as the primary clinical/scientific resource to HCPs for disease state and product information.
• Identify and engage relevant medical/therapeutic area experts and develop engagement plans.
• Support evidence generation (sponsor trials and IIS) and reporting.
• Identify and report medical insights and gaps to inform strategy.
• Present data to appropriate audiences in a compliant manner.
• Attend medical conferences to collect intelligence and inform internal partners.
• Ensure policies and financial controls are maintained with integrity.

Skills

KOL engagement

Oncology MSA

Clinical data interpretation

Scientific communication

Education

Terminal scientific degree (MD/PhD/PharmD/ etc.)

Job description

Regeneron Pharmaceuticals is seeking an Associate Director, Field Medical Affairs to build and maintain crucial KOL relationships across solid tumors and related oncology areas. You will serve as a primary clinical/scientific resource for HCPs and researchers, guiding evidence generation and educational initiatives.

Approximately 50% travel, territory ownership, and strong compliance with FDA/pharma regulations are expected as you contribute to strategic medical plans and interact with